CLINICAL_TRIALS
trial_result
· 2021-07-13
Clinical Trial Update: Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis [Phase 3]
Summary
Phase 3 trial assessing rilonacept for recurrent pericarditis completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kiniksa Pharmaceuticals (UK), Ltd. | Conditions: Recurrent Pericarditis | Phase 3 | Status: COMPLETED | Results posted: 2021-07-13